Related Experiment Video

Updated: Oct 12, 2026

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
13:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

The contribution of the RING finger domain of MDM2 to cell cycle progression

M Argentini1, N Barboule, B Wasylyk

  • 1Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP, Illkirch, France.

Oncogene
|August 22, 2000
PubMed

Insights

MDM2 oncoprotein accelerates cell cycle progression by interacting with p53. Its RING finger domain is crucial for this effect, independent of p53 degradation or p21 regulation.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • MDM2 oncoprotein inhibits p53 tumor suppressor activity.
  • MDM2 binds to p53, preventing G1 arrest and apoptosis.
  • Overexpression of MDM2 is implicated in various cancers.

Purpose of the Study:

  • To investigate the role of MDM2 in cell cycle regulation.
  • To determine the specific domains of MDM2 required for cell cycle progression.
  • To elucidate the relationship between MDM2's E3 ligase activity, p53 degradation, and cell cycle effects.

Main Methods:

  • Overexpression of wild-type and mutant MDM2 in RPM12650 cells.
  • Cell cycle analysis using flow cytometry.
  • Western blotting to assess p53 and p21 levels.
  • Reporter assays to measure p53 transcriptional activity.
  • Analysis of MDM2 E3 ligase activity and p53 degradation.

Main Results:

  • MDM2 overexpression accelerates cell cycle progression at the G1/S checkpoint.
  • The RING finger domain of MDM2 is essential for promoting cell cycle progression.
  • Mutants in the RING finger's zinc-binding sites retain cell cycle-stimulating activity despite lacking p53 degradation ability.
  • Alterations in the cryptic nucleolar localization sequence (KR motif) impair MDM2's cell cycle effects, p53 degradation, and E3 ligase activity.
  • RING mutants reduce the inhibition of p53-dependent reporters and endogenous p21CIP1/WAF1/SDI1.

Conclusions:

  • MDM2 promotes cell cycle progression through mechanisms independent of its E3 ligase activity and p53 degradation.
  • The RING finger domain plays a critical role in MDM2-mediated cell cycle regulation.
  • The KR motif is important for both MDM2's E3 ligase function and its cell cycle-promoting activity.

More Related Videos

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis08:33

Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis

Published on: December 5, 2017

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...